Pulmatrix (PULM) Current Leases (2019 - 2024)
Pulmatrix (PULM) posted Current Leases of $24000.0 for Q2 2024, down 93.73% sequentially from $383000.0 in Q1 2024, and down 93.3% YoY from $358000.0 in Q3 2023.
Pulmatrix (PULM) Current Leases (2019 - 2024) Analysis & Trends
Pulmatrix has reported Current Leases for 6 years, with the latest figure at $24000.0 in Q2 2024.
- Quarterly Current Leases fell 93.3% year-over-year to $24000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $24000.0 (down 93.3% YoY) and the FY2023 annual result came in at $429000.0, down 49.94% from the prior year.
- Current Leases eased to $24000.0 in Q2 2024 per PULM's latest filing, from $383000.0 in the prior quarter.
- Over five years, Current Leases peaked at $1.7 million in Q2 2022 and troughed at $24000.0 in Q2 2024.
- A 5-year average of $875222.2 and a median of $879500.0 in 2020 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2024: Current Leases soared 126.81% in 2021, then sank 93.3% in 2024.
- Over 5 years, Current Leases stood at $1.1 million in 2020, then increased by 26.08% to $1.4 million in 2021, then plunged by 40.11% to $857000.0 in 2022, then plunged by 49.94% to $429000.0 in 2023, then tumbled by 94.41% to $24000.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $24000.0, $383000.0, and $429000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Pulmatrix | 5.55 Mn | 5.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 383,000.00 |
| Dec 31, 2023 | 429,000.00 |
| Sep 30, 2023 | 199,000.00 |
| Jun 30, 2023 | 358,000.00 |
| Mar 31, 2023 | 779,000.00 |
| Dec 31, 2022 | 857,000.00 |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 898,000.00 |
| Jun 30, 2021 | 1.18 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.14 Mn |
| Sep 30, 2020 | 997,000.00 |
| Jun 30, 2020 | 861,000.00 |
| Mar 31, 2020 | 511,000.00 |
| Dec 31, 2019 | 675,000.00 |